Pharmaceutical companies and Iraq war contractors, both heavy Republican contributors, are among the companies scrambling to hire lobbyists with Democratic ties as they prepare for congressional investigative hearings next week.
Pfizer Inc., the world's biggest drugmaker, has hired the Glover Park Group, whose partners include Joe Lockhart, a former spokesman for President Bill Clinton, and Howard Wolfson, a spokesman for Senator Hillary Clinton's presidential campaign. Roche Holding AG picked as its lobbyist William Clyburn, cousin of the House's third-ranking Democrat, Jim Clyburn of South Carolina.
The increased hiring coincides with the Democratic congressional sweep that has sent shudders through corporate boardrooms.
``No general counsel or CEO wants to have to explain to his board why the company's name is appearing on the front page of a news article in a scandal,'' said Nick Allard, a partner in the law and lobbying firm of Patton Boggs LLP, which just landed military contractor Halliburton Co. as a client. ``Firms and industry groups that have not yet been represented are talking to firms all over town.''
Representative Henry Waxman, 67, the California Democrat who heads the House Oversight and Government Reform committee, plans to hold hearings beginning Feb. 6 on Iraq contractors. The committee has asked executives from Halliburton to testify.
``We're the main committee in the House of Representatives to look at matters that deserve scrutiny,'' Waxman said in an interview today. ``Nothing deserves scrutiny more than whether taxpayers' dollars are being used appropriately.''
[...]
Particularly Valuable
Lobbyists with Washington experience are considered particularly valuable when chief executive officers face nationally televised hearings. Waxman presided over one of the most famous on April 14, 1994, when seven tobacco- industry CEOs testified that they didn't add nicotine to their cigarettes.
Public hearings raise the stakes for corporations, said Mark Paoletta, a lawyer who helped run investigations for the House Energy and Commerce Committee when Republicans were in control. ``The company has a much larger risk with respect to its reputation'' than in civil litigation that can be resolved away from the public glare, he said.
Some Republican lobbyists are also benefiting from the increased congressional attention. Paoletta and another Energy and Commerce lawyer, Andrew Snowdon, just joined the Washington office of lobbying and law firm Dickstein Shapiro LLP.
Republican Firm
Mark Corallo and Barbara Comstock, two former Justice Department officials who have formed their own lobbying firm in Alexandria, Virginia, are talking to representatives of oil and drug companies. One of their current clients, Blackwater USA of Moyock, North Carolina, is scheduled to testify next week before Waxman's committee, Corallo said. The panel is probing possible waste and fraud in Iraq war contracts.
``When we realized that the political winds were blowing the other way, we understood there would be a market,'' said Corallo. Industries that ``escaped oversight'' for more than a decade ``are going to find themselves in the congressional crosshairs,'' he said.
The pharmaceutical industry, which the Center for Responsive Politics says gave 68 percent of its 2006 campaign gifts to Republicans, may be the biggest target for investigators. The House voted Jan. 12 to require the Medicare program, which provides health care for the elderly and disabled, to negotiate prices with drug companies; five congressional committees plan hearings into industry practices, including the generic-drug approval process and drug safety.
Number of Assignments
Paul Fitzhenry, a spokesman for New York-based Pfizer, and Glover Park partner Joel Johnson, a former Clinton administration and Senate Democratic staff member, said the group has handled a number of assignments for the drugmaker for about two years.
This year marks the first time Glover Park has registered as the company's lobbyists, congressional filings show. Johnson said the firm registered `` when it became evident that the inside role was to require outside contacts'' on legislative matters. Lockhart and Wolfson, the Glover Park partners, aren't listed on congressional forms as the firm's lobbyists for Pfizer.
William Clyburn didn't return phone calls seeking comment. Roche, based in Basel, Switzerland, had no immediate comment when asked about the investigations.
Thousand Oaks, California-based Amgen Inc., the world's largest biotechnology company, hired two firms in the last two months, congressional filings show. ``It certainly is a different political landscape,'' Amgen spokeswoman Kelley Davenport said.
Thursday, February 01, 2007
Scrambling for Lobbyists as hearing loom
Labels:
disease mongering,
drug companies,
drugs,
Hearing,
investigation,
politics,
USA
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment